We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
+7.75%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$219M
AUM Growth
+$15.6M
(+7.7%)
Cap. Flow
+$1.2M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
24.85%
Holding
101
New
4
Increased
36
Reduced
31
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$452K |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$365K |
| 3 |
UnitedHealth
UNH
|
+$213K |
| 4 |
Clorox
CLX
|
+$195K |
| 5 |
Qualcomm
QCOM
|
+$195K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$167K |
| 2 |
Colgate-Palmolive
CL
|
+$148K |
| 3 |
Mastercard
MA
|
+$134K |
| 4 |
Home Depot
HD
|
+$111K |
| 5 |
Pfizer
PFE
|
+$105K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.9% |
| 2 | Industrials | 13.7% |
| 3 | Healthcare | 12.56% |
| 4 | Financials | 10.53% |
| 5 | Consumer Staples | 10.45% |
Similar funds
SCV
TFP
CWM
MG
HWMG
AI
LSWM
IMA
Boston Research & Management's Q3 2018 Portfolio in Review
As of Q3 2018, Boston Research & Management held 101 positions worth $219M, up 7.7% from $203M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2018: portfolio turnover was 4%. Boston Research & Management opened 4 new positions and made no exits, leaving the 101-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
- Boston Research & Management's largest Q3 2018 buy was UnitedHealth: 818 shares worth $217K.
- Boston Research & Management added most to iShares Core MSCI EAFE ETF in Q3 2018, an estimated $452K increase.
- Boston Research & Management's biggest Q3 2018 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $167K.
- Boston Research & Management's ten largest holdings make up 25% of its $219M portfolio in Q3 2018.
- Boston Research & Management opened 4 new positions and closed 0 in Q3 2018.
- Boston Research & Management's portfolio value rose 7.7% quarter-over-quarter to $219M.
Based on Boston Research & Management's 13F filing for Q3 2018, filed 13 Nov 2018.